Introduction Semaglutide Has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://online-cancer-consultatio19636.timeblog.net/67348055/semaglutide-a-transformative-therapy-for-diabetes-obesity-and-heart-health